PS

Pratibha Srivastava

Children's Hospital of Philadelphia, University of Pennsylvania

ORCID iD 0000-0001-8563-7526

About

Pratibha Srivastava is a molecular biologist specializing in the development of therapeutic pancreatic beta cells with enhanced robustness and functionality. Utilizing cutting-edge CRISPR gene editing technology, Pratibha engineers have induced pluripotent stem cell (iPSC) lines to create next-generation beta cells, aiming to revolutionize treatments for Diabetes. Their work focuses on improving the viability and performance of these cells, addressing critical challenges in regenerative medicine and cell therapy. With a deep commitment to advancing translational science, Pratibha contributes to the growing field of precision medicine by bridging molecular biology, stem cell technology, and genome engineering.

Employment

  • Children's Hospital of Philadelphia Postdoctoral Researcher
    2023 - Present
  • University of Pennsylvania PostDoctoral Researcher
    2022 - 2023

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)